Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials
Taro Kishi, Nobumi Miyake, Makoto Okuya, et al.
Psychopharmacology (2020) Vol. 237, Iss. 11, pp. 3481-3487
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

N-Acetylcysteine (NAC): Impacts on Human Health
Micaely Cristina dos Santos Tenório, Nayara Gomes Graciliano, Fabiana Andréa Moura, et al.
Antioxidants (2021) Vol. 10, Iss. 6, pp. 967-967
Open Access | Times Cited: 295
The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders
Richard C. J. Bradlow, Michael Berk, Peter W. Kalivas, et al.
CNS Drugs (2022) Vol. 36, Iss. 5, pp. 451-482
Open Access | Times Cited: 55
Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder: A Systematic Review of Meta-Analyses
Maria S. Simon, Gara Arteaga-Henríquez, Ahmed Fouad Algendy, et al.
Neuropsychiatric Disease and Treatment (2023) Vol. Volume 19, pp. 1-25
Open Access | Times Cited: 30
Dietary habits, depression and obesity: an intricate relationship to explore in pediatric preventive strategies
Valeria Calcaterra, Virginia Rossi, Vittoria Carlotta Magenes, et al.
Frontiers in Pediatrics (2024) Vol. 12
Open Access | Times Cited: 8
Celecoxib for Mood Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Adam Gędek, Zofia Szular, Anna Antosik-Wójcińska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3497-3497
Open Access | Times Cited: 19
Nutrition-based interventions for mood disorders
Laís Bhering Martins, Jenneffer Rayane Braga Tibães, Marsal Sanches, et al.
Expert Review of Neurotherapeutics (2021) Vol. 21, Iss. 3, pp. 303-315
Closed Access | Times Cited: 40
N-acetylcysteine: Impact on Psychiatric Disorders
Sadia Binte Anwar Sonia, Muhammad Nurul Alam Siddiki, Sarmin Sultana, et al.
Advances in Human Biology (2025)
Open Access
N acetylcysteine in the treatment of alcohol use disorder: a randomized, double-blind, placebo-controlled trial
Kirsten C. Morley, Siena Peruch, Claire Adams, et al.
Alcohol and Alcoholism (2023) Vol. 58, Iss. 5, pp. 553-560
Closed Access | Times Cited: 12
Monoclonal antibody precision therapy targeting inflammation for bipolar disorder: a narrative review
Shijin Wu, Yuyang Zhou
Therapeutic Advances in Psychopharmacology (2024) Vol. 14
Open Access | Times Cited: 3
Mitochondrial Dysfunction as a Biomarker of Illness State in Bipolar Disorder: A Critical Review
Anna Giménez‐Palomo, Helena Andreu, Oscar De Juan, et al.
Brain Sciences (2024) Vol. 14, Iss. 12, pp. 1199-1199
Open Access | Times Cited: 3
Drugs with glutamate-based mechanisms of action in psychiatry
Adrian Andrzej Chrobak, Marcin Siwek
Pharmacological Reports (2024)
Open Access | Times Cited: 2
N‐acetylcysteine as an adjunctive treatment for bipolar depression: A systematic review and meta‐analysis of randomized controlled trials
Fabiano G. Nery, Wenbin Li, Melissa P. DelBello, et al.
Bipolar Disorders (2020) Vol. 23, Iss. 7, pp. 707-714
Closed Access | Times Cited: 20
Mitochondrial modulators in the treatment of bipolar depression: a systematic review and meta-analysis
Liang Liang, Junyu Chen, Ling Xiao, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
BPCO, troubles anxio-dépressifs et cognitifs : l’inflammation joue-t-elle un rôle prépondérant ?
G. Peiffer, M. Underner, J. Perriot, et al.
Revue des Maladies Respiratoires (2021) Vol. 38, Iss. 4, pp. 357-371
Open Access | Times Cited: 14
Depression interacts with allostatic load to predict cognitive decline in middle age
George Perlman, Hugo Cogo‐Moreira, Che‐Yuan Wu, et al.
Psychoneuroendocrinology (2022) Vol. 146, pp. 105922-105922
Closed Access | Times Cited: 9
Glutathione as a Molecular Marker of Functional Impairment in Patients with At-Risk Mental State: 7-Tesla 1H-MRS Study
Peter Jeon, Roberto Limongi, Sabrina D. Ford, et al.
Brain Sciences (2021) Vol. 11, Iss. 7, pp. 941-941
Open Access | Times Cited: 12
Reviewing the mitochondrial dysfunction paradigm in rodent models as platforms for neuropsychiatric disease research
Daniël J. van Rensburg, Jeremie Zander Lindeque, Brian H. Harvey, et al.
Mitochondrion (2022) Vol. 64, pp. 82-102
Closed Access | Times Cited: 8
Acetylsalicylic Acid and Mood Disorders: A Systematic Review
Monika Dominiak, Adam Gędek, Michalina Sikorska, et al.
Pharmaceuticals (2022) Vol. 16, Iss. 1, pp. 67-67
Open Access | Times Cited: 8
Partial Response to Antidepressant Treatment: The Role of Nutraceutical Compounds.
Nicolaja Girone, Beatrice Benatti, Laura Molteni, et al.
PubMed (2023) Vol. 20, Iss. 3, pp. 183-192
Closed Access | Times Cited: 4
Exploring the Novel Therapeutic Potential of N-acetylcysteine in Depression, Bipolar Disorders, and Anxiety
Reuben P. Syiem, Julie Birdie Wahlang, R. Krishnamoorthi, et al.
Journal of Pharmacology and Pharmacotherapeutics (2024) Vol. 15, Iss. 2, pp. 133-141
Open Access | Times Cited: 1
The effects of N-acetyl cysteine on intrinsic functional connectivity and neural alcohol cue reactivity in treatment-seeking individuals with alcohol use disorder: a preliminary study
Warren Logge, Paul Haber, Tristan Hurzeler, et al.
Psychopharmacology (2024)
Open Access | Times Cited: 1
N-Acetylcysteine Augmentation for Patients With Major Depressive Disorder and Bipolar Depression
Chittaranjan Andrade
The Journal of Clinical Psychiatry (2021) Vol. 82, Iss. 1
Open Access | Times Cited: 9
The effect of N-acetylcysteine on bipolar depression: a systematic review and meta-analysis of randomized controlled trials
Stefanos Pittas, Xenophon Theodoridis, Anna‐Bettina Haidich, et al.
Psychopharmacology (2021) Vol. 238, Iss. 7, pp. 1729-1736
Closed Access | Times Cited: 9
Can pharmacotherapy improve treatment outcomes in people with co-occurring major depressive and cocaine use disorders?
Gustavo A. Angarita, Hasti Hadizadeh, I. Laynez Cerdena, et al.
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 13, pp. 1669-1683
Open Access | Times Cited: 9
Nutrition, Exercise, and Stress Management for Treatment and Prevention of Psychiatric Disorders. A Narrative Review Psychoneuroendocrineimmunology-Based
Francesco Bottaccioli, Anna Giulia Bottaccioli, Enrica Marzola, et al.
Endocrines (2021) Vol. 2, Iss. 3, pp. 226-240
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top